The main purpose of this legislation is to explore the potential benefits of peptide-based therapies for veterans receiving care through the Department of Veterans Affairs (VA). It aims to assess whether these therapies could improve health outcomes for veterans, particularly in areas such as recovery, rehabilitation, chronic pain management, and mental health. The key provisions of the legislation require the Secretary of Veterans Affairs to conduct a thorough review of existing regulations and guidance related to peptides.